Israel · Delayed Price · Currency is ILS · Price in ILA Gencell Statistics
Total Valuation
Gencell has a market cap or net worth of ILS 40.70 million. The enterprise value is 78.96 million.
| Market Cap | 40.70M |
| Enterprise Value | 78.96M |
Important Dates
The next estimated earnings date is Friday, November 27, 2026.
| Earnings Date | Nov 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Gencell has 45.52 million shares outstanding. The number of shares has increased by 50.39% in one year.
| Current Share Class | 45.52M |
| Shares Outstanding | 45.52M |
| Shares Change (YoY) | +50.39% |
| Shares Change (QoQ) | +97.30% |
| Owned by Insiders (%) | 4.87% |
| Owned by Institutions (%) | 7.24% |
| Float | 35.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.23 |
| PB Ratio | 1.10 |
| P/TBV Ratio | 1.10 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 17.90 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.54, with a Debt / Equity ratio of 1.27.
| Current Ratio | 1.54 |
| Quick Ratio | 1.22 |
| Debt / Equity | 1.27 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -31.31 |
Financial Efficiency
Return on equity (ROE) is -55.81% and return on invested capital (ROIC) is -23.08%.
| Return on Equity (ROE) | -55.81% |
| Return on Assets (ROA) | -19.69% |
| Return on Invested Capital (ROIC) | -23.08% |
| Return on Capital Employed (ROCE) | -27.99% |
| Weighted Average Cost of Capital (WACC) | 4.44% |
| Revenue Per Employee | 294,011 |
| Profits Per Employee | -1.43M |
| Employee Count | 15 |
| Asset Turnover | 0.06 |
| Inventory Turnover | 2.68 |
Taxes
In the past 12 months, Gencell has paid 12,788 in taxes.
| Income Tax | 12,788 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.82% in the last 52 weeks. The beta is 0.71, so Gencell's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | -28.82% |
| 50-Day Moving Average | 77.64 |
| 200-Day Moving Average | 101.64 |
| Relative Strength Index (RSI) | 57.93 |
| Average Volume (20 Days) | 33,997 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Gencell had revenue of ILS 4.41 million and -21.48 million in losses. Loss per share was -0.65.
| Revenue | 4.41M |
| Gross Profit | -4.98M |
| Operating Income | -22.97M |
| Pretax Income | -21.47M |
| Net Income | -21.48M |
| EBITDA | -24.48M |
| EBIT | -22.97M |
| Loss Per Share | -0.65 |
Balance Sheet
The company has 8.70 million in cash and 46.96 million in debt, with a net cash position of -38.26 million or -0.84 per share.
| Cash & Cash Equivalents | 8.70M |
| Total Debt | 46.96M |
| Net Cash | -38.26M |
| Net Cash Per Share | -0.84 |
| Equity (Book Value) | 37.09M |
| Book Value Per Share | 0.84 |
| Working Capital | 4.86M |
Cash Flow
In the last 12 months, operating cash flow was -14.10 million and capital expenditures -93,312, giving a free cash flow of -14.20 million.
| Operating Cash Flow | -14.10M |
| Capital Expenditures | -93,312 |
| Depreciation & Amortization | -1.51M |
| Net Borrowing | 388,947 |
| Free Cash Flow | -14.20M |
| FCF Per Share | -0.31 |
Margins
| Gross Margin | -112.91% |
| Operating Margin | -520.88% |
| Pretax Margin | -486.76% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Gencell does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -50.39% |
| Shareholder Yield | -50.39% |
| Earnings Yield | -72.54% |
| FCF Yield | -34.88% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 19, 2025. It was a reverse split with a ratio of 0.2.
| Last Split Date | Oct 19, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.2 |
Scores
Gencell has an Altman Z-Score of -19.21 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -19.21 |
| Piotroski F-Score | 1 |